Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$30,586,622
+$1,234,756 QoQ
Shares Held
120,434
+0.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#578
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. JNJ ranks #1 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
120,434 | $30,586,622 | |
| 2 | LLY |
ELI LILLY & Co
|
22,840 | $27,394,983 | |
| 3 | ABBV |
AbbVie Inc.
|
70,717 | $17,795,225 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,665 | $12,164,452 | |
| 5 | PFE |
Pfizer Inc
|
307,330 | $7,400,506 | |
| 6 | AMGN |
Amgen Inc
|
14,884 | $5,389,794 | |
| 7 | NVS |
Novartis AG
|
28,770 | $4,508,834 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
62,967 | $3,628,158 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,586,622 | 120,434 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $29,351,866 | 120,078 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $25,162,222 | 121,586 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $22,596,208 | 121,865 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,310,044 | 126,416 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $20,258,848 | 122,159 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $17,955,440 | 124,156 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $20,318,434 | 125,376 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $18,311,363 | 125,283 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $20,079,373 | 126,932 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $18,774,003 | 119,778 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,237,857 | 117,097 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $19,543,442 | 118,073 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $18,354,790 | 118,418 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $21,477,636 | 121,583 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $20,178,227 | 123,520 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $23,019,319 | 129,679 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $22,586,722 | 127,443 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $21,130,737 | 123,521 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,042,796 | 124,104 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $20,600,901 | 125,051 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $20,109,044 | 122,355 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $19,754,180 | 125,519 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $19,064,679 | 128,054 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $16,854,786 | 119,852 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $13,359,262 | 101,878 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||